clinical trial · NCT01470144
Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension
Actelion·phase3·completed·n = 41
Pulmonary Arterial HypertensionEpoprostenol
brief summary
This is an open-label, nonrandomized extension to study AC-066A301. The study will assess safety and tolerability of ACT-385781A while providing a means for continuing treatment after ending participation in study AC-066A301.
started
Jun 1, 2011
primary completion
Jun 1, 2015
completion
Jul 1, 2015
last updated
Feb 4, 2025
official title
An Open-label Extension of Study AC-066A301 Investigating the Safety and Tolerability of ACT-385781A in Patients With Pulmonary Arterial Hypertension (PAH)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol